Rtw Investments, LP has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $6.27 Billion distributed in 68 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Madrigal Pharmaceuticals, Inc. with a value of $423M, Axsome Therapeutics, Inc. with a value of $376M, Avidity Biosciences, Inc. with a value of $374M, Argenx Se with a value of $355M, and Natera, Inc. with a value of $330M.
Examining the 13F form we can see an increase of $285M in the current position value, from $5.99B to 6.27B.
Rtw Investments, LP is based out at New York, NY
Below you can find more details about Rtw Investments, LP portfolio as well as his latest detailed transactions.